Skip to main content
SpringerLink
Log in

Use of the Quinolones in Paediatrics

  • State-of-The-Art Presentations
  • Published:
Drugs Aims and scope Submit manuscript

Summary

For many years, quinolone-induced cartilage toxicity observed in experiments involving immature animals has represented an indisputable contraindication for the use of these promising antimicrobials in prepubertal patients. Clinical, magnetic resonance imaging and histopathological monitoring of patients receiving ciprofloxacin at the University of Berne, together with published data, suggest that the quinolones do not cause arthropathy in humans. Conditions that potentially qualify for quinolone use (especially ciprofloxacin) in children include oral antipseudomonal (or antistaphylococcal) therapy for pulmonary exacerbations in cystic fibrosis, and complicated urinary tract, skeletal, aural and shunt infections. In addition to these rarer indications, there is an urgent need for the quinolones in developing countries for children with endemic and epidemic shigellosis and invasive salmonellosis. At present, these compounds are not approved for paediatric use and therefore must be administered as part of a controlled study or on a compassionate use basis in individual patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Adam D. Use of quinolones in pediatric patients. Reviews of Infectious Diseases 11 (Suppl. 5): S1113–S1116, 1989

    Article  PubMed  Google Scholar 

  • Amacher DE, Schomaker SJ, Gootz TD, McGuirk PR. Proteoglycan and procollagen syntheses in rat embryo limb bud cultures treated with quinolone antibacterials. Alternative Methods in Toxicology 7: 307–312, 1989

    CAS  Google Scholar 

  • Bavdekar A, Chaudhari M, Bhave S, Pandit A. Ciprofloxacin in typhoid fever. Indian Journal of Pediatrics 58: 335–339, 1991

    Article  PubMed  CAS  Google Scholar 

  • Bendele AM, Hulman JF, Harvey AK, Hrubey PS, Chandrasekhar S. Passive role of articular chondrocytes in quinolone-induced arthropathy in guinea pigs. Toxicologic Pathology 18: 304–312, 1990

    Article  PubMed  CAS  Google Scholar 

  • Black A, Redmond AOB, Steen HJ, Oborska IT. Tolerance and safety of ciprofloxacin in pediatric patients. Journal of Antimicrobial Chemotherapy 26 (Suppl. F): 25–29, 1990

    PubMed  Google Scholar 

  • Blumberg HM, Rimland D, Carroll DJ, Terry P, Wachsmuth IK. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. Journal of Infectious Diseases 163: 1279–1285, 1991

    Article  PubMed  CAS  Google Scholar 

  • Brand HS, van Kampen GP, van der Korst JK. Effect of nalidixic acid, pipemidic acid and cinoxacin on chondrocyte metabolism in explants of articular cartilage. Clinical and Experimental Rheumatology 8: 393–395, 1990

    PubMed  CAS  Google Scholar 

  • Burkhardt JE, Hill MA, Carlton WW, Kesterson JW. Histologic and histochemical changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Veterinary Pathology 27: 162–170, 1990

    Article  PubMed  CAS  Google Scholar 

  • Burkhardt JE, Hill MA, Turek JJ, Carlton WW. Ultrastructural changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Veterinary Pathology 29: 230–238, 1992

    Article  PubMed  CAS  Google Scholar 

  • Cheesbrough JS, Mwema FI, Green SDR, Tillotson GS. Quinolones in children with invasive salmonellosis. Lancet 338: 127, 1991

    Article  PubMed  CAS  Google Scholar 

  • Christ W, Lehnert T, Ulbrich B. Specific toxicologie aspects of the quinolones. Reviews of Infectious Diseases 10 (Suppl. 1): S141–S146, 1988

    Article  PubMed  CAS  Google Scholar 

  • Chysky V, Kapila K, Hullmann R, Arcieri G, Schacht P, et al. Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation. Infection 19: 289–296, 1991

    CAS  Google Scholar 

  • Courvalin P. Plasmid-mediated 4-quinolone resistance: a real or apparent absence? Antimicrobial Agents and Chemotherapy 34: 681–684, 1990

    Article  PubMed  CAS  Google Scholar 

  • Davies BI, Maesen FPV. Drug interactions with quinolones. Reviews of Infectious Diseases 11 (Suppl. 5): S1083–S1090, 1989

    Article  PubMed  CAS  Google Scholar 

  • Gootz TD, Barrett JF, Sutcliffe JA. Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systems. Antimicrobial Agents and Chemotherapy 34: 8–12, 1990

    Article  PubMed  CAS  Google Scholar 

  • Gough A, Barsoum NJ, Mitchell L, McGuire EJ, de la Iglesia FA. Juvenile canine drug-induced arthropathy: clinicopathological studies on articular lesions caused by oxolinic and pipemidic acids. Toxicology and Applied Pharmacology. 51: 177–187, 1979

    Article  PubMed  CAS  Google Scholar 

  • Hoffmann K, Desprechins B. Joint lesions induced by quinolones — differences between clinical, MRI and post-mortem findings. Proceedings 3rd International Symposium on New Quinolones, European Journal of Clinical Microbiology and Infectious Diseases (Special Issue): 383, 1991

  • Huber-Spitzy V, Steinkogler FJ, Huber E, Schiffbanker M. Norfloxacin in the treatment of congenital dacryocystitis. Orbit 10: 37–40, 1991

    Article  Google Scholar 

  • Hussey G, Kibel M, Parker N. Ciprofloxacin treatment of multiply drug-resistant extrapulmonary tuberculosis in a child. Pediatric Infectious Disease Journal 5: 408–409, 1992

    Google Scholar 

  • Kato M, Onodera T. Morphological investigation of cavity formation in articular cartilage induced by oxaflocin in rats. Fundamental and Applied Toxicology 11: 110–119, 1988a

    Article  PubMed  CAS  Google Scholar 

  • Kato M, Onodera T. Effect of ofloxacin on the uptake of [3H]thymidine by articular cartilage cells in the rat. Toxicology Letters 44: 131–142, 1988b

    Article  PubMed  CAS  Google Scholar 

  • LeBel M. Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal. European Journal of Clinical Microbiology and Infectious Diseases 10: 316–324, 1991

    Article  CAS  Google Scholar 

  • Leysen DC, Haemers A, Pattyn SR. Mycobacteria and the new quinolones. Antimicrobial Agents and Chemotherapy 33: 1–5, 1989

    Article  PubMed  CAS  Google Scholar 

  • Lolekha S, Vibulbandhitkit S, Poonyarit P. Response to antimicrobial therapy for shigellosis in Thailand. Reviews of Infectious Diseases 13 (Suppl. 4): S342–S346, 1991

    Article  PubMed  Google Scholar 

  • Lumbiganon P, Pengsaa K, Sookpranee T. Ciprofloxacin in neonates and its possible adverse effect on the teeth. Pediatric Infectious Disease Journal 8: 619–620, 1991

    Google Scholar 

  • Machida M, Kisajima H, Aijima H, Maeda A, Ishida R, et al. Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals. Toxicology and Applied Pharmacology 105: 403–412, 1990

    Article  PubMed  CAS  Google Scholar 

  • Miller MS, Gaido F, Rourk Jr MH, Spock A. Anaphylactoid reactions to ciprofloxacin in cystic fibrosis patients. Pediatric Infectious Disease Journal 10: 164–165, 1991

    Article  PubMed  CAS  Google Scholar 

  • Norrby SR. Side-effects of quinolones: comparison between quinolones and other antibiotics. European Journal of Clinical Microbiology and Infectious Diseases 10: 378–383, 1991

    Article  CAS  Google Scholar 

  • O’Mahony MS, Fitzgerald MX. Cystic fibrosis and seizures. Lancet 338: 259, 1991

    Article  PubMed  Google Scholar 

  • Peltola H, Väärälä M, Renkonen O-V, Neuvonen PJ. Pharmacokinetics of single-dose oral ciprofloxacin in infants and small children. Antimicrobial Agents and Chemotherapy 36: 1086–1090, 1992

    Article  PubMed  CAS  Google Scholar 

  • Pertuiset E, Lenoir G, Jehanne M, Douchain F, Guillot M, et al. Tolérance articulaire de la péfloxacine et de l’ofloxacine chez les enfants et adolescents atteints de mucoviscidose. Revue du Rhumatisme et des Maladies Osteo-Articulai res 56: 735–740, 1989

    CAS  Google Scholar 

  • Phillips BM, David TJ. Pathogenesis and management of arthropathy in cystic fibrosis. Journal of the Royal Society of Medicine 79 (Suppl. 12): 44–50, 1986

    PubMed  Google Scholar 

  • Radberg G, Nilsson LE, Svensson S. Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin. Antimicrobial Agents and Chemotherapy 34: 1242–1247, 1990

    Article  Google Scholar 

  • Schaad UB. Use of quinolones in pediatrics. European Journal of Clinical Microbiology and Infectious Diseases 10: 355–360, 1991

    Article  CAS  Google Scholar 

  • Schaad UB, Sander E, Wedgwood J, Schaffner T. Morphological studies for skeletal toxicity after prolonged ciprofloxacin therapy in two juvenile cystic fibrosis patients. Pediatric Infectious Disease Journal, in press, 1992

  • Schaad UB, Stoupis C, Wedgwood J, Tschaeppeler H, Vock P. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatric Infectious Disease Journal 10: 723–729, 1991

    PubMed  CAS  Google Scholar 

  • Schaad UB, Wedgwood-Krucko J. Nalidixic acid in children: retrospective matched controlled study for cartilage toxicity. Infection 15: 165–168, 1987

    Article  PubMed  CAS  Google Scholar 

  • Schaad UB, Wedgwood-Krucko J, Guenin K, Buehlmann U, Kraemer R. Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin. European Journal of Clinical Microbiology and Infectious Diseases 8: 858–865, 1989

    Article  CAS  Google Scholar 

  • Schlüter G. Toxicology of ciprofloxacin. In Neu HC, Weuta H (Eds) First international ciprofloxacin workshop. Current Clinical Practice Series. Excerpta Medica 34: 61–70, 1986

    Google Scholar 

  • Schlüter G. Ciprofloxacin: toxicologie evaluation of additional safety data. American Journal of Medicine 87 (Suppl. 5A): 37–39, 1989

    Article  Google Scholar 

  • Simpson J, Watson AR, Mellersh A, Nelson CS, Dodd K. Typhoid fever, ciprofloxacin, and renal failure. Archives of Diseases in Childhood 60: 1083–1084, 1991

    Article  Google Scholar 

  • Stahlmann R, Merker HJ, Hinz N, Chahoud I, Webb J, et al. Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations. Archives of Toxicology 64: 193–204, 1990

    CAS  Google Scholar 

  • Tyrrell RL, Gluckert K, Pathria M, Modic MT. Fast three-dimensional MR imaging of the knee: comparison with arthroscopy. Radiology 166: 865–872, 1988

    PubMed  CAS  Google Scholar 

  • Valerius NH, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 338:725–726, 1991

    Article  PubMed  CAS  Google Scholar 

  • Wolfson JS. Quinolone antimicrobial agents: adverse effects and bacterial resistance. European Journal of Clinical Microbiology and Infectious Diseases 8: 1080–1092, 1989

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Berne, Inselspital, CH-3010, Berne, Switzerland

    Urs B. Schaad

Authors
  1. Urs B. Schaad
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schaad, U.B. Use of the Quinolones in Paediatrics. Drugs 45 (Suppl 3), 37–41 (1993). https://doi.org/10.2165/00003495-199300453-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199300453-00008

Keywords

Search

Navigation